Skip to main content

Table 1 Baseline characteristics of the sample randomized in to three intervention arms (n = 96)

From: Vitamin D supplementation in obese Sri Lankan children: a randomized controlled trial

Parameter

Supplementation (n = 33)

Mean (SD)

Treatment (n = 32)

Mean (SD)

Placebo (n = 31)

Mean (SD)

Age (years)

9.75 (2.26)

9.95 (2.02)

10.61 (1.83)

Gender*

Male

22 (66.7%)

22 (67.7%)

25 (80.6%)

Female

11 (33.3%)

10 (32.3%)

6 (19.4%)

Ethnicity*a

Sinhala

23 (69.7%)

20 (64.5%)

23 (74.2%)

Tamil

3 (9.1%)

4 (12.9%)

3 (10.5%)

Muslim

7 (21.2%)

7 (19.4%)

5 (16.1%)

BMI SDS

2.83 (0.86)

2.72 (0.65)

2.66 (0.55)

Height SDS

0.64 (1.53)

0.66 (1.09)

0.50 (1.32)

Waist Circumference SDS

3.22 (0.72)

3.04 (0.62)

2.91 (0.56)

Percentage fat mass

43.31 (4.95)

41.89 (4.07)

41.94 (4.31)

Systolic BP SDS

−1.33 (0.82)

−1.29 (0.78)

− 1.41 (0.87)

Diastolic BP SDS

0.86 (0.77)

0.82 (0.64)

0.94 (0.68)

Vitamin D (ng/ml)

14.92 (3.92)

14.92 (3.04)

15.47 (2.78)

Parathyroid hormone (pg/ml)

36.41 (26.47)

37.24 (18.13)

34.19 (15.37)

Alkaline Phosphatase (IU/L)

262.79 (87.27)

243.0 (56.27)

270.29 (74.72)

Serum Calcium (mg/dl)

9.64 (0.46)

9.72 (0.48)

9.71 (0.58)

Fasting Blood glucose (mg/dl)

86.18 (8.62)

83.19 (5.28)

83.5 (6.17)

2-h OGTT (mg/dl)

119.25 (21.08)

112.48 (18.84)

116.63 (21.84)

Fasting Insulin (μIU/ml)

15.87 (8.96)

12.86 (8.58)

12.16 (8.47)

2-h Insulin (μIU/ml)

118.6 (85.3)

109.1 (88.2)

11.9 (88.0)

Total cholesterol (mg/dl)

198.27 (39.39)

183.94 (35.09)

176.98 (41.26)

Triglycerides (mg/dl)

108.36 (46.76)

103.53 (57.79)

129.16 (67.57)

HDL (mg/dl)

38.48 (7.28)

41.53 (10.22)

41.55 (9.59)

LDL (mg/dl)

138.11 (33.62)

123.11 (32.24)

115.63 (29.11)

AST (IU/l)

31.88 (10.29)

38.38 (31.85)

31.45 (15.38)

ALT (IU/l)

33.72 (21.39)

39.22 (51.37)

29.42 (27.73)

AST/ALT

1.1764 (0.68)

1.39 (0.71)

1.38 (0.77)

ALP (IU/L)

262.79 (87.27)

243.0 (56.27)

270.29 (74.72)

HS-CRP (mg/l)

4.41 (3.53)

3.83 (4.36)

3.562 (3.13)

Serum Ca (mg/dl)

9.64 (0.46)

9.72 (0.48)

9.71 (0.58)

HOMA IR

3.45 (2.12)

2.598 (1.79)

2.529 (1.81)

  1. * Number and percentage are given aOne missing value was observed for ethnicity in treatment arm
  2. BMI Body mass index, WC Waist circumference, SDS SD score, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, OGTT Oral glucose tolerance test, PTH Parathyroid hormone, FBS Fasting Blood Sugar, HDL High-density Lipoprotein, LDL Low-density lipoprotein, AST Aspartate transaminase, ALT Alanine transaminase, ALP Alkaline phosphatase, Hs-CRS High sensitivity C reactive protein, FM Fat mass, HOMA-IR Insulin Resistance using homeostatic model
  3. None of the parameters showed a statistically significant difference between the three intervention arms